跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Difflam-C - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Difflam-C
Approved
STANDARD
Difflam-C
Ensign Laboratories Pty. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
eff4c4b7b3af4db2
Company
Ensign Laboratories Pty. Ltd.
Type
Standard
Approval Details
Approval Id
eff4c4b7b3af4db2
Drug Approval Philippines Name
Difflam-C
Product Name
Difflam-C
Registration Number
DR-XY41264
Brand Name
Difflam-C
Generic Name
Benzydamine hydrochloride + Chlorhexidine gluconate.
Dosage Form
Solution
Dosage Strength
22.5 mg/18 mg per 15 mL
Manufacturer
Ensign Laboratories Pty. Ltd.
Importer
iNova Pharma Philippines Inc.
Distributor
iNova Pharma Philippines Inc.
Issuance Date
28 May 2024
Expiry Date
28 May 2029
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID) / Antiseptic
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
eff4c4b7b3af4db2
Type
Standard
Back to Philippines FDA Approvals